These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 12923453

  • 1. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD, Tuan TL, Bowdish ME, Jin YS, Starnes VA, Cramer DV, Barr ML.
    Transplantation; 2003 Aug 15; 76(3):609-14. PubMed ID: 12923453
    [Abstract] [Full Text] [Related]

  • 2. Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection.
    Wu GD, Bowdish ME, Jin YS, Zhu H, Mitsuhashi N, Barsky LW, Barr ML.
    J Heart Lung Transplant; 2005 Dec 15; 24(12):2160-9. PubMed ID: 16364866
    [Abstract] [Full Text] [Related]

  • 3. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ, Bicknell GR, Nicholson ML.
    Transpl Int; 2003 May 15; 16(5):347-53. PubMed ID: 12759727
    [Abstract] [Full Text] [Related]

  • 4. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK, Plummer MS, Hilton G, Pieper GM, Ledbetter S.
    Circulation; 2004 Dec 21; 110(25):3822-9. PubMed ID: 15583082
    [Abstract] [Full Text] [Related]

  • 5. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH.
    Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186
    [Abstract] [Full Text] [Related]

  • 6. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Nephrol Dial Transplant; 2008 Nov 27; 23(11):3446-55. PubMed ID: 18558624
    [Abstract] [Full Text] [Related]

  • 7. PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts.
    Tuuminen R, Nykänen AI, Krebs R, Soronen J, Pajusola K, Keränen MA, Koskinen PK, Alitalo K, Lemström KB.
    Arterioscler Thromb Vasc Biol; 2009 May 27; 29(5):691-8. PubMed ID: 19213942
    [Abstract] [Full Text] [Related]

  • 8. Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung.
    Yoshida S, Iwata T, Chiyo M, Smith GN, Foresman BH, Mickler EA, Heidler KM, Cummings OW, Fujisawa T, Brand DD, Baker A, Wilkes DS.
    Transplantation; 2007 Mar 27; 83(6):799-808. PubMed ID: 17414715
    [Abstract] [Full Text] [Related]

  • 9. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W, Schneeberger S, Seiler R, Stroka DM, Amberger A, Offner F, Candinas D, Margreiter R.
    Transplantation; 2003 Apr 15; 75(7):940-5. PubMed ID: 12698077
    [Abstract] [Full Text] [Related]

  • 10. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H, Welter H, Kraetzl WD, Steffl M, Meyer HH, Schams D, Berisha B.
    Reproduction; 2007 Sep 15; 134(3):535-47. PubMed ID: 17709571
    [Abstract] [Full Text] [Related]

  • 11. Genetic modulation of CD44 expression by intragraft fibroblasts.
    Wu GD, Wang H, Zhu H, He Y, Barr ML, Klein AS.
    J Biochem; 2008 Nov 15; 144(5):571-80. PubMed ID: 18776204
    [Abstract] [Full Text] [Related]

  • 12. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
    Nicholson ML, Waller JR, Bicknell GR.
    Br J Surg; 2002 Jul 15; 89(7):933-7. PubMed ID: 12081746
    [Abstract] [Full Text] [Related]

  • 13. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.
    Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN.
    N Engl J Med; 2001 Jul 12; 345(2):93-7. PubMed ID: 11450677
    [Abstract] [Full Text] [Related]

  • 14. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2008 Jul 12; 59(4):189-94. PubMed ID: 19391484
    [Abstract] [Full Text] [Related]

  • 15. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R, Nykänen A, Keränen MA, Krebs R, Alitalo K, Koskinen PK, Lemström KB.
    Transplant Proc; 2006 Dec 12; 38(10):3271-3. PubMed ID: 17175246
    [Abstract] [Full Text] [Related]

  • 16. [Antisense TGF-beta 1 transfection decreases acute and chronic rejection in allografts].
    Redaelli CA, Schilling MK, Hullett DA, Büchler MW, Sollinger HW.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Dec 12; 115(Suppl I):699-704. PubMed ID: 14518344
    [Abstract] [Full Text] [Related]

  • 17. Induction of transforming growth factor-beta during cardiac allograft rejection.
    Waltenberger J, Wanders A, Fellström B, Miyazono K, Heldin CH, Funa K.
    J Immunol; 1993 Jul 15; 151(2):1147-57. PubMed ID: 8335896
    [Abstract] [Full Text] [Related]

  • 18. Confirmation of alternatively spliced platelet-derived growth factor-A chain and correlation with expression of PDGF receptor-alpha in human cardiac allografts.
    Zhao XM, Frist WH, Yeoh TK, Miller GG.
    Transplantation; 1995 Feb 27; 59(4):605-11. PubMed ID: 7878765
    [Abstract] [Full Text] [Related]

  • 19. Expression of platelet-derived growth factor receptor in rat heart allografts.
    Higgy NA, Davidoff AW, Grothman GT, Hollenberg MD, Benediktsson H, Paul LC.
    J Heart Lung Transplant; 1991 Feb 27; 10(6):1012-22. PubMed ID: 1661606
    [Abstract] [Full Text] [Related]

  • 20. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 27; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.